Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05425420 · ClinicalTrials.gov registry record · Phase 1
Single Dose IV Methadone for Post-Op Pain
A Phase 1 study, sponsored by Kanecia Obie Zimmerman.
- Completed
- Registry status
- Phase 1
- Development phase
- 22
- Enrollment target
NCT05425420 is a Phase 1 study that has completed, run by Kanecia Obie Zimmerman. The registered enrollment target is 22 participants.
The verdict
NCT05425420, a Phase 1 study, has completed, sponsored by Kanecia Obie Zimmerman.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 22 participants
- Enrollment target
Study Summary
Single-center, open label, single-session study to evaluate methadone pharmacokinetics and pharmacodynamic in adults.
Interventions
- DRUG methadone hydrochloride 0.1mg/kg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2023-08-11 |
| Est. Completion | 2024-01-20 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05425420
The ClinicalTrials.gov registry entry for NCT05425420 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kanecia Obie Zimmerman, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which methadone hydrochloride 0.1mg/kg is the first listed.
NCT05425420 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05425420 about?
NCT05425420 is a clinical study titled "Single Dose IV Methadone for Post-Op Pain". Single-center, open label, single-session study to evaluate methadone pharmacokinetics and pharmacodynamic in adults.
What is the current status of trial NCT05425420?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 22 participants. The study started on 2023-08-11. Estimated completion is 2024-01-20.
What interventions are being tested in trial NCT05425420?
The interventions under investigation include: methadone hydrochloride 0.1mg/kg (DRUG).
Who is sponsoring clinical trial NCT05425420?
This trial is sponsored by Kanecia Obie Zimmerman, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.